Measurement, Classification and Evaluation of Sleep Disturbance in Psoriasis: A Systematic Review

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Jun 22

PMID 27327082

Citations 21

Authors

Alasdair L Henry

Simon D Kyle

Sahil Bhandari

Anna Chisholm

Christopher E M Griffiths

Christine Bundy

Affiliations

Soon will be listed here.

Abstract

Background: Psoriasis is a long-term immune-mediated inflammatory disorder mainly, but not only, affecting skin, and is associated with significant medical and psychological morbidity. Evidence suggests that sleep is disrupted in psoriasis, however high quality empirical evidence is lacking. Given the importance of sleep for health, characterisation of sleep disruption in psoriasis is an important goal. We therefore conducted a systematic review of the sleep-psoriasis literature.

Methods: Searches were conducted in Pubmed, SCOPUS and Web of Science from inception to May 2016. Studies were compared against inclusion/exclusion criteria and underwent a quality evaluation. Given the heterogeneity of studies, we conducted a narrative synthesis of the findings.

Results: Searches revealed 32 studies which met our predetermined inclusion/exclusion criteria. Whilst 93.7% of studies reported sleep disruption in this population, ranging from 0.05% to 85.4%, many had important methodological shortcomings. Over half of all quantitative studies (54.8%; 17/31) relied on non-validated measures, contributing to heterogeneity in study findings. In those that employed valid measures, assessing sleep was often not the primary objective. We frequently found the absence of adequate sample size calculations and poor statistical reporting.

Conclusion: This review showed that in psoriasis, reported sleep rates of sleep disturbance varied substantially. Most studies lacked a hypothesis driven research question and/or failed to use validated measures of sleep. We were unable to draw firm conclusions about the precise prevalence and nature of sleep disturbance within the psoriasis population. We offer suggestions to help advance understanding of sleep disturbance in psoriasis.

Citing Articles

Sleep quality and risk of obstructive sleep apnea in psoriasis and hidradenitis suppurativa patients.

Baran B, Oksum Solak E, Yetkin N, Rabahoglu B, Tutar N, Gulmez I Arch Dermatol Res. 2025; 317(1):185.

PMID: 39775297 DOI: 10.1007/s00403-024-03734-2.

Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study.

Li X, Ding Y, Zhang C, Lu Y, Li F, Pan W Adv Ther. 2024; 42(1):146-163.

PMID: 39347926 DOI: 10.1007/s12325-024-02976-w.

Determinants of Consumers' Acceptance and Adoption of Novel Food in View of More Resilient and Sustainable Food Systems in the EU: A Systematic Literature Review.

Laureati M, De Boni A, Saba A, Lamy E, Minervini F, Delgado A Foods. 2024; 13(10).

PMID: 38790835 PMC: 11120339. DOI: 10.3390/foods13101534.

Investigating Chronotype and Sleep Quality in Psoriatic Patients: Results from an Observational, Web-Based Survey.

Borghi A, De Giorgi A, Monti A, Cappadona R, Manfredini R, Corazza M J Pers Med. 2023; 13(11).

PMID: 38003919 PMC: 10672655. DOI: 10.3390/jpm13111604.

Association Between Poor Sleep and Myocardial Infarction in Patients with Psoriasis: Findings from a Cross-Sectional Study with the National Psoriasis Foundation.

Spencer R, Jin J, Elhage K, Davis M, Hakimi M, Gondo G Dermatol Ther (Heidelb). 2023; 13(11):2903-2909.

PMID: 37798556 PMC: 10613158. DOI: 10.1007/s13555-023-01045-4.

References

Maari C, Bolduc C, Nigen S, Marchessault P, Bissonnette R . Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial. J Dermatolog Treat. 2012; 25(1):57-60. DOI: 10.3109/09546634.2012.713458. View

Simpson N, Dinges D . Sleep and inflammation. Nutr Rev. 2008; 65(12 Pt 2):S244-52. DOI: 10.1111/j.1753-4887.2007.tb00371.x. View

Nyunt W, Low W, Ismail R, Sockalingam S, Min A . Determinants of health-related quality of life in psoriasis patients in Malaysia. Asia Pac J Public Health. 2013; 27(2):NP662-73. DOI: 10.1177/1010539513492561. View

Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U . Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011; 135(1-3):10-9. DOI: 10.1016/j.jad.2011.01.011. View

Laugsand L, Vatten L, Platou C, Janszky I . Insomnia and the risk of acute myocardial infarction: a population study. Circulation. 2011; 124(19):2073-81. DOI: 10.1161/CIRCULATIONAHA.111.025858. View

Fernandez-Mendoza J, Vgontzas A, Liao D, Shaffer M, Vela-Bueno A, Basta M . Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012; 60(4):929-35. PMC: 3679545. DOI: 10.1161/HYPERTENSIONAHA.112.193268. View

Delfino Jr M, Holt E, Taylor C, Wittenberg E, Qureshi A . Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriasis: a pilot study. J Am Acad Dermatol. 2008; 59(3):439-47. DOI: 10.1016/j.jaad.2008.05.032. View

Gowda S, Goldblum O, McCall W, Feldman S . Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol. 2009; 63(1):114-23. DOI: 10.1016/j.jaad.2009.07.003. View

Palagini L, Bruno R, Gemignani A, Baglioni C, Ghiadoni L, Riemann D . Sleep loss and hypertension: a systematic review. Curr Pharm Des. 2012; 19(13):2409-19. DOI: 10.2174/1381612811319130009. View

10.

Egeberg A, Khalid U, Gislason G, Mallbris L, Skov L, Hansen P . Psoriasis and Sleep Apnea: A Danish Nationwide Cohort Study. J Clin Sleep Med. 2015; 12(5):663-71. PMC: 4865552. DOI: 10.5664/jcsm.5790. View

11.

Thorburn P, Riha R . Skin disorders and sleep in adults: where is the evidence?. Sleep Med Rev. 2010; 14(6):351-8. DOI: 10.1016/j.smrv.2009.12.001. View

12.

Gupta M, Gupta A . Sleep-wake disorders and dermatology. Clin Dermatol. 2012; 31(1):118-26. DOI: 10.1016/j.clindermatol.2011.11.016. View

13.

Sharma N, Koranne R, Singh R . Psychiatric morbidity in psoriasis and vitiligo: a comparative study. J Dermatol. 2001; 28(8):419-23. DOI: 10.1111/j.1346-8138.2001.tb00003.x. View

14.

Karaca S, Fidan F, Erkan F, Nural S, Pinarci T, Gunay E . Might psoriasis be a risk factor for obstructive sleep apnea syndrome?. Sleep Breath. 2012; 17(1):275-80. DOI: 10.1007/s11325-012-0686-2. View

15.

Buysse D, Ancoli-Israel S, Edinger J, Lichstein K, Morin C . Recommendations for a standard research assessment of insomnia. Sleep. 2006; 29(9):1155-73. DOI: 10.1093/sleep/29.9.1155. View

16.

Morin C, Belleville G, Belanger L, Ivers H . The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011; 34(5):601-8. PMC: 3079939. DOI: 10.1093/sleep/34.5.601. View

17.

Knutson K, Spiegel K, Penev P, Van Cauter E . The metabolic consequences of sleep deprivation. Sleep Med Rev. 2007; 11(3):163-78. PMC: 1991337. DOI: 10.1016/j.smrv.2007.01.002. View

18.

Ljosaa T, Mork C, Stubhaug A, Moum T, Wahl A . Skin pain and skin discomfort is associated with quality of life in patients with psoriasis. J Eur Acad Dermatol Venereol. 2011; 26(1):29-35. DOI: 10.1111/j.1468-3083.2011.04000.x. View

19.

Balta I, Karadag A, Selek S, Onder S, Kanbay A, Burakgazi-Yilmaz H . General psychiatric symptoms, quality of sleep, and coping strategies in patients with psoriasis vulgaris. Int J Dermatol. 2015; 55(1):60-4. DOI: 10.1111/ijd.12649. View

20.

Hirotsu C, Nogueira H, Albuquerque R, Tomimori J, Tufik S, Andersen M . The bidirectional interactions between psoriasis and obstructive sleep apnea. Int J Dermatol. 2015; 54(12):1352-8. DOI: 10.1111/ijd.13026. View